The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peltz, G. A.
Right arrow Articles by Moore, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peltz, G. A.
Right arrow Articles by Moore, K. W.

The Journal of Immunology, Vol 141, Issue 6 1891-1896, Copyright © 1988 by American Association of Immunologists


ARTICLES

Cloned and expressed human Fc receptor for IgG mediates anti-CD3- dependent lymphoproliferation

GA Peltz, ML Trounstine and KW Moore
Department of Immunology, DNAX Research Institute, Palo Alto, CA 94304.

We have utilized gene transfer experiments to investigate the role of a human monocyte receptor for IgG (Fc gamma RII) in mouse IgG1 anti-CD3 (Leu 4)-induced lymphoproliferation in vitro. Mouse Ltk- cells expressing human Fc gamma RII or a mutant of Fc gamma RII lacking the entire cytoplasmic domain of the receptor mediate anti-CD3-induced lymphoproliferation in cultures of adherent cell-depleted human PBMC. Expression of an Fc gamma RII mutant lacking transmembrane and cytoplasmic domains (soluble Fc gamma RII) in COS7 cells yielded a secreted receptor which retained affinity for IgG, even in the absence of the mutant receptor's N-linked oligosaccharides. Soluble Fc gamma RII inhibits rosette formation by human IgG-sensitized RBC and the Fc gamma RII-bearing cell line K562, but does not sitmulate anti-CD3- induced lymphoproliferation under the conditions tested.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. L. Ellsworth, M. Maurer, B. Harder, N. Hamacher, M. Lantry, K. B. Lewis, S. Rene, K. Byrnes-Blake, S. Underwood, K. S. Waggie, et al.
Targeting Immune Complex-Mediated Hypersensitivity with Recombinant Soluble Human Fc{gamma}RIA (CD64A)
J. Immunol., January 1, 2008; 180(1): 580 - 589.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ho, S. Moir, L. Kulik, A. Malaspina, E. T. Donoghue, N. J. Miller, W. Wang, T.-W. Chun, A. S. Fauci, and V. M. Holers
Role for CD21 in the Establishment of an Extracellular HIV Reservoir in Lymphoid Tissues
J. Immunol., June 1, 2007; 178(11): 6968 - 6974.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Hoffmann, R. Eder, T. J. Boeld, K. Doser, B. Piseshka, R. Andreesen, and M. Edinger
Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion
Blood, December 15, 2006; 108(13): 4260 - 4267.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Hoffmann, R. Eder, L. A. Kunz-Schughart, R. Andreesen, and M. Edinger
Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
Blood, August 1, 2004; 104(3): 895 - 903.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Dall'Ozzo, S. Tartas, G. Paintaud, G. Cartron, P. Colombat, P. Bardos, H. Watier, and G. Thibault
Rituximab-Dependent Cytotoxicity by Natural Killer Cells: Influence of FCGR3A Polymorphism on the Concentration-Effect Relationship
Cancer Res., July 1, 2004; 64(13): 4664 - 4669.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. N. D'Souza, L. C. Edelstein, P. M. Pegman, S. M. Smith, S. T. Loughran, A. Clarke, A. Mehl, M. Rowe, C. Gelinas, and D. Walls
Nuclear Factor {kappa}B-Dependent Activation of the Antiapoptotic bfl-1 Gene by the Epstein-Barr Virus Latent Membrane Protein 1 and Activated CD40 Receptor
J. Virol., February 15, 2004; 78(4): 1800 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. Avril, S. Iochmann, D. Brand, P. Bardos, H. Watier, and G. Thibault
Human Choriocarcinoma Cell Resistance to Natural Killer Lysis Due to Defective Triggering of Natural Killer Cells
Biol Reprod, August 1, 2003; 69(2): 627 - 633.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Nagumo, K. Agematsu, N. Kobayashi, K. Shinozaki, S. Hokibara, H. Nagase, M. Takamoto, K. Yasui, K. Sugane, and A. Komiyama
The different process of class switching and somatic hypermutation; a novel analysis by CD27- naive B cells
Blood, January 15, 2002; 99(2): 567 - 575.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Dubois, C. Barthelemy, I. Durand, Y.-J. Liu, C. Caux, and F. Briere
Toward a Role of Dendritic Cells in the Germinal Center Reaction: Triggering of B Cell Proliferation and Isotype Switching
J. Immunol., March 15, 1999; 162(6): 3428 - 3436.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Dubois, C. Massacrier, B. Vanbervliet, J. Fayette, F. Briere, J. Banchereau, and C. Caux
Critical Role of IL-12 in Dendritic Cell-Induced Differentiation of Naive B Lymphocytes
J. Immunol., September 1, 1998; 161(5): 2223 - 2231.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Marth and B. L. Kelsall
Regulation of Interleukin-12 by Complement Receptor 3 Signaling
J. Exp. Med., June 2, 1997; 185(11): 1987 - 1995.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
B. Dubois, B. Vanbervliet, J. Fayette, C. Massacrier, C. V. Kooten, F. Briere, J. Banchereau, and C. Caux
Dendritic Cells Enhance Growth and Differentiation of CD40-activated B Lymphocytes
J. Exp. Med., March 3, 1997; 185(5): 941 - 952.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J Banchereau, P de Paoli, A Valle, E Garcia, and F Rousset
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40
Science, January 4, 1991; 251(4989): 70 - 72.
[Abstract] [PDF]


Home page
ScienceHome page
K. Moore, P Vieira, D. Fiorentino, M. Trounstine, T. Khan, and T. Mosmann
Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
Science, June 8, 1990; 248(4960): 1230 - 1234.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.